Combination Chemotherapy Drugs for Advanced Ovarian Cancer
Links shared publicly online about this topic
Advanced ovarian cancer: Avastin-chemotherapy combination followed by Avastin alone improves PFS
buzzup.com — “Genentech, Inc., a wholly owned member of the Roche Group, today announced that a Phase III study showed the combination of Avastin® (bevacizumab) and chemotherapy followed by maintenance use of Avastin alone increased the time women with previously untreated advanced ovarian cancer lived without the disease worsening (progression-free survival or PFS), compared to chemotherapy alone. A preliminary assessment of safety noted adverse events previously observed in pivotal trials of Avasti” View full resource at buzzup.com
Most Recently Shared on February 25, 2010 at 6:28 pm By:
Ovarian Cancer News: Advanced ovarian cancer: Avastin-chemotherapy combination followed by Avastin alone improv... http://buzzup.com/oyli_
Advanced ovarian cancer: Avastin-chemotherapy combination followed by Avastin alone improves PFS
news-medical.net — “Genentech, Inc., a wholly owned member of the Roche Group, today announced that a Phase III study showed the combination of Avastin® (bevacizumab) and chemotherapy followed by maintenance use of Avastin alone increased the time women with previously untreated advanced ovarian cancer lived without the disease worsening (progression-free survival or PFS), compared to chemotherapy alone. A preliminary assessment of safety noted adverse events previously observed in pivotal trials of Avastin.” View full resource at news-medical.net
Most Recently Shared on February 25, 2010 at 10:40 am By:
Pregnancy News: Advanced ovarian cancer: Avastin-chemotherapy combination followed by Avastin alone improves PFS: ... http://bit.ly/aOjZqK
Key advances in ovarian cancer (ASCO 2010 ) Video
vodpod.com — “Prof Jonathan Ledermann outlines some of the key advances in ovarian cancer that have been presented at ASCO 2010. Prof Ledermann discusses research demonstrating the effectiveness of combining bevacizumab with chemotherapy as first line treatment of ovarian cancer. A second key presentation was research indicating that PARP inhibitors are effective at treating not just ovarian cancer caused by BRCA mutation but also high grade serous cancer. If this result is confirmed in further studies, it wo” View full resource at vodpod.com
Most Recently Shared on July 22, 2010 at 9:59 pm By:
Paul Cacciatore Patient Advocate
Prof Jonathan Ledermann outlines some of the key advances in ovarian cancer that have been presented at ASCO 2010. Pro… http://bit.ly/b7acun
Leukemia Drug May Help Some Ovarian Cancer Patients
health.msn.com — “Leukemia Drug May Help Some Ovarian Cancer Patients” View full resource at health.msn.com
Most Recently Shared on November 12, 2009 at 2:51 pm By:
Leukemia Drug May Help Some Ovarian Cancer Patients http://bit.ly/3rtd1
Medical News: SGO: Drug Combination Slows Recurrent Ovarian Cancer - in Meeting Coverage, SGO from MedPage Today
medpagetoday.com — “SAN FRANCISCO -- Combination chemotherapy resulted in a longer, progression-free survival (PFS) than did sequential therapy in a randomized clinical trial of patients with recurrent, platinum-sensitiv” View full resource at medpagetoday.com
Most Recently Shared on March 15, 2010 at 2:41 pm By:
SGO: Drug Combination Slows Recurrent Ovarian Cancer (CME/CE) SAN FRANCISCO (MedPage Today) -- Combination chemothera.. http://bit.ly/bNbtkZ
New treatment regimen shown effective against advanced ovarian cancer
physorg.com — “Newly reported results from a major clinical trial show that adding bevacizumab (Avastin) to standard frontline chemotherapy for women with advanced ovarian cancer and then continuing a maintenance dose of the drug afterwards significantly extends progression-free survival. Women receiving the new treatment ...” View full resource at physorg.com
Most Recently Shared on June 6, 2010 at 4:50 pm By:
PhysOrg Health News Health News
New treatment regimen shown effective against advanced ovarian cancer http://tw.physorg.com/195047400
Bevacizumab extends progression-free survival in women with advanced ovarian cancer
news-medical.net — “Newly reported results from a major clinical trial show that adding bevacizumab (Avastin) to standard frontline chemotherapy for women with advanced ovarian cancer and then continuing a maintenance dose of the drug afterwards significantly extends progression-free survival. Women receiving the new treatment regimen saw no worsening of their disease for 14.1 months, compared to 10.3 months for women receiving standard therapy.” View full resource at news-medical.net
Most Recently Shared on June 7, 2010 at 12:55 pm By:
Ovarian Cancer News: Bevacizumab extends progression-free survival in women with advanced ovarian cancer: Newly ... http://buzzup.com/zltp
Avastin Phase III Study Shows Positive Results In Women With Advanced Ovarian Cancer
medicalnewstoday.com — “Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that a phase III study showed the combination of Avastin (bevacizumab) and chemotherapy followed by maintenance use of Avastin increased the time women” View full resource at medicalnewstoday.com
Most Recently Shared on February 27, 2010 at 4:04 pm By:
MNT Ovarian Cancer Health News
Avastin Phase III Study Shows Positive Results In Women With Advanced Ovarian Cancer http://mnt.to/3yfN #ovariancancer
Genentech Announces Positive Results Of Avastin Phase III Study In Women With Advanced Ovarian Cancer
medicalnewstoday.com — “Genentech, Inc., a wholly owned member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced that a Phase III study showed the combination of Avastin® (bevacizumab) and chemotherapy follo” View full resource at medicalnewstoday.com
Most Recently Shared on February 26, 2010 at 9:37 am By:
Genentech Announces Positive Results Of Avastin Phase III Study In Women With Advanced Ovarian Cancer Genentech, Inc... http://bit.ly/9W9nfb
New treatment regimen shown effective against advanced ovarian cancer
eurekalert.org — “Newly reported results from a major clinical trial show that adding bevacizumab (Avastin) to standard frontline chemotherapy for women with advanced ovarian cancer and then continuing a maintenance dose of the drug afterwards significantly extends progression-free survival. Women receiving the new treatment regimen saw no worsening of their disease for 14.1 months, compared to 10.3 months for women receiving standard therapy.” View full resource at eurekalert.org
Most Recently Shared on June 6, 2010 at 6:53 pm By:
New treatment regimen shown effective against advanced ovarian cancer: (Fox Chase Cancer Center) Newly reported re... http://bit.ly/a8Fohc
Studies Examine Treatment Options For Ovarian Cancer Patients
medicalnewstoday.com — “Long-term use of the cancer medication Avastin may help women with ovarian cancer live longer without their cancer progressing, new research shows. Experimental drug NKTR-102 produced substantial” View full resource at medicalnewstoday.com
Most Recently Shared on June 8, 2010 at 2:06 pm By:
MNT Ovarian Cancer Health News
Studies Examine Treatment Options For Ovarian Cancer Patients http://mnt.to/3DCJ #ovariancancer
DiaTech Oncology MiCK Chemotherapy Induced Apoptosis Assay Shows Increased Response And Survival In Ovarian Cancer Patients
medicalnewstoday.com — “DiaTech Oncology announced that the American Society of Cancer Oncology (ASCO) has published the results of a comprehensive study to determine the effectiveness of the Microculture Kinetic (MiCK)” View full resource at medicalnewstoday.com
Most Recently Shared on May 28, 2010 at 2:07 pm By:
MNT Ovarian Cancer Health News
DiaTech Oncology MiCK Chemotherapy Induced Apoptosis Assay Shows Increased Response And Survival In Ovarian Cancer Pat... http://mnt.to/3DdD
New Chemo Regimen May Benefit Ovarian Cancer Patients - Drugs.com MedNews
drugs.com — “Dose-dense chemotherapy improves survival in women with advanced ovarian cancer, Japanese researchers say. Currently, paclitaxel and carboplatin given every thr” View full resource at drugs.com
Most Recently Shared on September 21, 2009 at 10:13 pm By:
New Chemo Regimen May Benefit Ovarian Cancer Patients - http://bit.ly/3PogLx
Medical News: ASCO: Targeted Drug Fails to Slow Advanced Ovarian Ca - in Meeting Coverage, ASCO from MedPage Today
medpagetoday.com — “CHICAGO -- Women with advanced ovarian cancer gained no survival benefit when treated with the investigational agent enzastaurin in addition to chemotherapy, according to a study reported here.” View full resource at medpagetoday.com
Most Recently Shared on June 9, 2011 at 4:12 pm By:
ASCO: Targeted Drug Fails to Slow Advanced Ovarian Ca http://bit.ly/mfDWtC
Medical News: ASCO: Targeted Drug Fails to Slow Advanced Ovarian Ca - in Meeting Coverage, ASCO from MedPage Today
medpagetoday.com — “CHICAGO -- Women with advanced ovarian cancer gained no survival benefit when treated with the investigational agent enzastaurin in addition to chemotherapy, according to a study reported here.” View full resource at medpagetoday.com
Most Recently Shared on June 9, 2011 at 4:11 pm By:
ASCO: Targeted Drug Fails to Slow Advanced Ovarian Ca http://bit.ly/mNo2oV
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
News-Medical.Net
Stay up to date with the latest Ovarian Cancer news and research via News-Medical.Net
-
News-Medical.Net
Stay up to date with the latest Pregnancy news and research via News-Medical.Net
-
Paul Cacciatore
Founder of Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
Advertisement
